Abstract: Aging and age-related ailments have emerged as critical challenges and great burdens within the global contemporary society. Addressing these concerns is an imperative task, with the aims of postponing the aging process and finding effective treatments for age-related degenerative diseases. Recent investigations have highlighted the significant roles of nicotinamide adenine dinucleotide (NAD⁺) in the realm of anti-aging. It has been empirically evidenced that supplementation with nicotinamide mononucleotide (NMN) can elevate NAD⁺ levels in the body, thereby ameliorating certain age-related degenerative diseases. The principal anti-aging mechanisms of NMN essentially lie in its impact on cellular energy metabolism, inhibition of cell apoptosis, modulation of immune function, and preservation of genomic stability, which collectively contribute to the deferral of the aging process. This paper critically reviews and evaluates existing research on the anti-aging mechanisms of NMN, elucidates the inherent limitations of current research, and proposes novel avenues for anti-aging investigations.

烟酰胺单核苷酸的功能及其抗衰老作用的研究进展

[1]AbdellatifM, SedejS, KroemerG, 2021. NAD⁺ metabolism in cardiac health, aging, and disease. Circulation, 144(22):1795-1817.

[2]AflatounianA, ParisVR, RichaniD, et al., 2022. Declining muscle NAD⁺ in a hyperandrogenism PCOS mouse model: possible role in metabolic dysregulation. Mol Metab, 65:101583.

[3]AmjadS, NisarS, BhatAA, et al., 2021. Role of NAD⁺ in regulating cellular and metabolic signaling pathways. Mol Metab, 49:101195.

[4]BaiP, CantoC, BrunyánszkiA, et al., 2011a. PARP-2 regulates SIRT1 expression and whole-body energy expenditure. Cell Metab, 13(4):450-460.

[5]BaiP, CantoC, OudartH, et al., 2011b. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab, 13(4):461-468.

[6]BelenkyP, BoganKL, BrennerC, 2007. NAD⁺ metabolism in health and disease. Trends Biochem Sci, 32(1):12-19.

[7]BertoldoMJ, ListijonoDR, HoWHJ, et al., 2020. NAD⁺ repletion rescues female fertility during reproductive aging. Cell Rep, 30(6):1670-1681.e7.

[8]BritoS, BaekJM, ChaB, et al., 2022. Nicotinamide mononucleotide reduces melanin production in aged melanocytes by inhibiting cAMP/Wnt signaling. J Dermatol Sci, 106(3):159-169.

[9]Camacho-PereiraJ, TarragoMG, ChiniCCS, et al., 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab, 23(6):1127-1139.

[10]ChalkiadakiA, GuarenteL, 2015. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer, 15(10):608-624.

[11]ChenXH, AmorimJA, MoustafaGA, et al., 2020. Neuroprotective effects and mechanisms of action of nicotinamide mononucleotide (NMN) in a photoreceptor degenerative model of retinal detachment. Aging, 12(24):24504-24521.

[12]ChiniCCS, PeclatTR, WarnerGM, et al., 2020. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD⁺ and NMN levels. Nat Metab, 2(11):1284-1304.

[13]CohenMS, 2020. Interplay between compartmentalized NAD⁺ synthesis and consumption: a focus on the PARP family. Genes Dev, 34(5-6):254-262.

[14]CovarrubiasAJ, PerroneR, GrozioA, et al., 2021. NAD⁺ metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol, 22(2):119-141.

[15]CrosC, MargierM, CannelleH, et al., 2022. Nicotinamide mononucleotide administration triggers macrophages reprogramming and alleviates inflammation during sepsis induced by experimental peritonitis. Front Mol Biosci, 9:895028.

[16]de VosM, SchreiberV, DantzerF, 2012. The diverse roles and clinical relevance of PARPs in DNA damage repair: current state of the art. Biochem Pharmacol, 84(2):137-146.

[17]di StefanoM, Nascimento-FerreiraI, OrsomandoG, et al., 2015. A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration. Cell Death Differ, 22(5):731-742.

[18]FangEF, Scheibye-KnudsenM, BraceLE, et al., 2014. Defective mitophagy in XPA via PARP-1 hyperactivation and NAD⁺/SIRT1 reduction. Cell, 157(4):882-896.

[19]FangEF, KassahunH, CroteauDL, et al., 2016. NAD⁺ replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metab, 24(4):566-581.

[20]FletcherRS, RatajczakJ, DoigCL, et al., 2017. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells. Mol Metab, 6(8):819-832.

[21]FrederickDW, LoroE, LiuL, et al., 2016. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab, 24(2):269-282.

[22]GartenA, GrohmannT, KluckovaK, et al., 2019. Sorafenib-induced apoptosis in hepatocellular carcinoma is reversed by SIRT1. Int J Mol Sci, 20(16):4048.

[23]HouYJ, LautrupS, CordonnierS, et al., 2018. NAD⁺ supplementation normalizes key Alzheimer’s features and DNA damage responses in a new ad mouse model with introduced DNA repair deficiency. Proc Natl Acad Sci USA, 115(8):E1876-E1885.

[24]HsuCP, OkaS, ShaoD, et al., 2009. Nicotinamide phosphoribosyltransferase regulates cell survival through NAD⁺ synthesis in cardiac myocytes. Circ Res, 105(5):481-491.

[25]HuangP, ZhouY, TangWH, et al., 2022. Long-term treatment of Nicotinamide mononucleotide improved age-related diminished ovary reserve through enhancing the mitophagy level of granulosa cells in mice. J Nutr Biochem, 101:108911.

[26]ImaiSI, 2011. Dissecting systemic control of metabolism and aging in the NAD world: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett, 585(11):1657-1662.

[27]IrieJ, InagakiE, FujitaM, et al., 2020. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J, 67(2):153-160.

[28]JiangY, WangD, ZhangC, et al., 2023. Nicotinamide mononucleotide restores oxidative stress-related apoptosis of oocyte exposed to benzyl butyl phthalate in mice. Cell Prolif, 56(8):e13419.

[29]JiangYF, LiuTT, LeeCH, et al., 2020. The NAD⁺-mediated self-inhibition mechanism of pro-neurodegenerative SARM1. Nature, 588(7839):658-663.

[30]KaneAE, SinclairDA, 2018. Sirtuins and NAD⁺ in the development and treatment of metabolic and cardiovascular diseases. Circ Res, 123(7):868-885.

[31]LiL, HanQ, ChenY, et al., 2023. β-nicotinamide mononucleotide rescues the quality of aged oocyte and improves subsequent embryo development in pigs. PLoS ONE, 18(10):e0291640.

[32]LuoCT, DingWX, YangCM, et al., 2022. Nicotinamide mononucleotide administration restores redox homeostasis via the Sirt3‒Nrf2 axis and protects aged mice from oxidative stress-induced liver injury. J Proteome Res, 21(7):1759-1770.

[33]MargierM, KuehnemannC, HuloN, et al., 2023. Nicotinamide mononucleotide administration prevents doxorubicin-induced cardiotoxicity and loss in physical activity in mice. Cells, 12(1):108.

[34]MengF, ZhangYN, DuJY, et al., 2024. Nicotinamide mononucleotide maintains cytoskeletal stability and fortifies mitochondrial function to mitigate oocyte damage induced by triocresyl phosphate. Ecotoxicol Environ Saf, 275:116264.

[35]MiaoYL, CuiZK, GaoQ, et al., 2020. Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes. Cell Rep, 32(5):107987.

[36]MillsKF, YoshidaS, SteinLR, et al., 2016. Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metab, 24(6):795-806.

[37]MonzelAS, EnríquezJA, PicardM, 2023. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab, 5(4):546-562.

[38]NomiyamaT, SetoyamaD, YasukawaT, et al., 2022. Mitochondria metabolomics reveals a role of β-nicotinamide mononucleotide metabolism in mitochondrial DNA replication. J Biochem, 171(3):325-338.

[39]OkabeK, YakuK, TobeK, et al., 2019. Implications of altered NAD metabolism in metabolic disorders. J Biomed Sci, 26:34.

[40]PalmerAK, JensenMD, 2022. Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest, 132(16):e158451.

[41]Piedra-QuinteroZL, WilsonZ, NavaP, et al., 2020. CD38: an immunomodulatory molecule in inflammation and autoimmunity. Front Immunol, 11:597959.

[42]PoddarSK, SifatAE, HaqueS, et al., 2019. Nicotinamide mononucleotide: exploration of diverse therapeutic applications of a potential molecule. Biomolecules, 9:34.

[43]PuQ, GuoXX, HuJJ, et al., 2022. Nicotinamide mononucleotide increases cell viability and restores tight junctions in high-glucose-treated human corneal epithelial cells via the SIRT1/Nrf2/HO-1 pathway. Biomed Pharmacother, 147:112659.

[44]RevolloJR, KörnerA, MillsKF, et al., 2007. Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab, 6(5):363-375.

[45]SanadaS, KomuroI, KitakazeM, 2011. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol, 301(5):H1723-H1741.

[46]ShenQ, ZhangSJ, XueYZ, et al., 2021. Biological synthesis of nicotinamide mononucleotide. Biotechnol Lett, 43(12):2199-2208.

[47]SinghAK, MohantyA, KumarSL, et al., 2024. Diminished NAD+ levels and activation of retrotransposons promote postovulatory aged oocyte (POAO) death. Cell Death Discov, 10:104.

[48]SurjanaD, HallidayGM, MartinAJ, et al., 2012. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol, 132(5):1497-1500.

[49]SurjanaD, HallidayGM, DamianDL, 2013. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin. Carcinogenesis, 34(5):1144-1149.

[50]TakedaK, OkumuraK, 2021. Nicotinamide mononucleotide augments the cytotoxic activity of natural killer cells in young and elderly mice. Biomed Res, 42(5):173-179.

[51]ThompsonBC, SurjanaD, HallidayGM, et al., 2014. Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in primary melanocytes. Exp Dermatol, 23(7):509-511.

[52]TongD, SchiattarellaGG, JiangN, et al., 2021. NAD⁺ repletion reverses heart failure with preserved ejection fraction. Circ Res, 128(11):1629-1641.

[53]VermaK, JaiswalR, PaliwalS, et al., 2023. An insight into PI3K/Akt pathway and associated protein‒protein interactions in metabolic syndrome: a recent update. J Cell Biochem, 124(7):923-942.

[54]WalkerMA, TianR, 2018. Raising NAD in heart failure: time to translate? Circulation, 137(21):2274-2277.

[55]WalkerMA, ChenH, YadavA, et al., 2023. Raising NAD⁺ level stimulates short-chain dehydrogenase/reductase proteins to alleviate heart failure independent of mitochondrial protein deacetylation. Circulation, 148(25):2038-2057.

[56]WangH, SunYA, PiCC, et al., 2022. Nicotinamide mononucleotide supplementation improves mitochondrial dysfunction and rescues cellular senescence by NAD⁺/Sirt3 pathway in mesenchymal stem cells. Int J Mol Sci, 23(23):14739.

[57]WangLQ, ZhaoMY, QianR, et al., 2023. Nicotinamide mononucleotide ameliorates silica-induced lung injury through the Nrf2-regulated glutathione metabolism pathway in mice. Nutrients, 15(1):143.

[58]WangQH, LiY, DouDY, et al., 2021. Nicotinamide mononucleotide-elicited NAMPT signaling activation aggravated adjuvant-induced arthritis in rats by affecting peripheral immune cells differentiation. Int Immunopharmacol, 98:107856.

[59]WątrobaM, DudekI, SkodaM, et al., 2017. Sirtuins, epigenetics and longevity. Ageing Res Rev, 40:11-19.

[60]YooKH, TangJJ, RashidMA, et al., 2021. Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments. Cancer Res, 81(13):3727-3737.

[61]YoshinoJ, MillsKF, YoonMJ, et al., 2011. Nicotinamide mononucleotide, a key NAD⁺ intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab, 14(4):528-536.

[62]YoshinoM, YoshinoJ, KayserBD, et al., 2021. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547):1224-1229.

[63]YuP, MaSC, DaiXC, et al., 2020. Inhibitive effect of nicotinamide mononucleotide on angiotensin II-induced cardiac fibrosis in mice and its mechanism. Chin J Mult Organ Dis Elderly, 19(6):452-456 (in Chinese).

[64]ZhangGZ, DengYJ, XieQQ, et al., 2020. Sirtuins and intervertebral disc degeneration: roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta, 508:33-42.

[65]ZhangRL, ShenYY, ZhouL, et al., 2017. Short-term administration of nicotinamide mononucleotide preserves cardiac mitochondrial homeostasis and prevents heart failure. J Mol Cell Cardiol, 112:64-73.

[66]ZhaoC, LiWJ, DuanHY, et al., 2020. NAD⁺ precursors protect corneal endothelial cells from UVB-induced apoptosis. Am J Physiol Cell Physiol, 318(4):C796-C805.

[67]ZhaoYZ, LiH, GuoQL, et al., 2023. Multiple characteristic alterations and available therapeutic strategies of cellular senescence. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 24(2):101-114.

[68]ZhouB, WangDDH, QiuYH, et al., 2020. Boosting NAD level suppresses inflammatory activation of PBMCs in heart failure. J Clin Invest, 130(11):6054-6063.

[69]ZhouXR, DuHH, NiLY, et al., 2021. Nicotinamide mononucleotide combined with lactobacillus fermentum TKSN041 reduces the photoaging damage in murine skin by activating AMPK signaling pathway. Front Pharmacol, 12:643089.